Unknown PHASE2 INTERVENTIONAL 2-arm NCT00102908

Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density

Bisphosphonate Therapy for HIV-Associated Osteopenia

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions HIV Infections Osteopenia Osteoporosis

Interventions Zoledronate Zoledronate placebo

Updated 6 times since 2017 Last updated: Sep 25, 2008 Started: May 31, 2005 Primary completion: Oct 31, 2007 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00102908, this PHASE2 trial focuses on HIV Infections and Osteopenia and remains ongoing. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 6 times since 2005, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Allergy and Infectious Diseases (NIAID)

Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Diego, United States